Fluorodeoxyglucose-positron-emission Tomography Imaging of Head and Neck Squamous Cell Cancer

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2009 Nov 14

PMID 19910448

Citations 34

Authors

R M Subramaniam

M Truong

P Peller

O Sakai

G Mercier

Affiliations

Soon will be listed here.

Abstract

The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

Citing Articles

The Prognostic and Diagnostic Value of [F]FDG PET/CT in Untreated Laryngeal Carcinoma.

Al-Ibraheem A, Abdlkadir A, Al-Adhami D, Hejleh T, Mansour A, Mohamad I J Clin Med. 2023; 12(10).

PMID: 37240619 PMC: 10218884. DOI: 10.3390/jcm12103514.

Predicting local persistence/recurrence after radiation therapy for head and neck cancer from PET/CT using a multi-objective, multi-classifier radiomics model.

Zhang Q, Wang K, Zhou Z, Qin G, Wang L, Li P Front Oncol. 2022; 12:955712.

PMID: 36248979 PMC: 9557184. DOI: 10.3389/fonc.2022.955712.

Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study.

Ng S, Cardenas C, Bahig H, Elgohari B, Wang J, Johnson J Curr Oncol. 2022; 29(9):6303-6313.

PMID: 36135064 PMC: 9498049. DOI: 10.3390/curroncol29090495.

Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study.

Guha A, Anjari M, Cook G, Goh V, Connor S Front Oncol. 2022; 12:784693.

PMID: 35242703 PMC: 8886142. DOI: 10.3389/fonc.2022.784693.

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.

Boschert V, Teusch J, Muller-Richter U, Brands R, Hartmann S Int J Mol Sci. 2022; 23(2).

PMID: 35054968 PMC: 8775697. DOI: 10.3390/ijms23020775.

References

Kao C, Changlai S, Chieng P, Yen R, Yen T . Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol. 1998; 16(11):3550-5. DOI: 10.1200/JCO.1998.16.11.3550. View

Forastiere A, Koch W, Trotti A, Sidransky D . Head and neck cancer. N Engl J Med. 2002; 345(26):1890-900. DOI: 10.1056/NEJMra001375. View

Brkovich V, Miller F, Karnad A, Hussey D, McGuff H, Otto R . The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope. 2006; 116(6):855-8. DOI: 10.1097/01.mlg.0000214668.98592.d6. View

Layland M, Sessions D, Lenox J . The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005; 115(4):629-39. DOI: 10.1097/01.mlg.0000161338.54515.b1. View

Porceddu S, Jarmolowski E, Hicks R, Ware R, Weih L, Rischin D . Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck. 2005; 27(3):175-81. DOI: 10.1002/hed.20130. View

Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N . Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 2003; 44(2):198-206. View

Wong W, Chevretton E, McGurk M, Hussain K, Davis J, Beaney R . A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci. 1997; 22(3):209-14. DOI: 10.1046/j.1365-2273.1997.00852.x. View

Wong R, Lin D, Schoder H, Patel S, Gonen M, Wolden S . Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002; 20(20):4199-208. DOI: 10.1200/JCO.2002.02.590. View

Schwartz D, Rajendran J, Yueh B, Coltrera M, Anzai Y, Krohn K . Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg. 2003; 129(11):1173-8. DOI: 10.1001/archotol.129.11.1173. View

10.

Manolidis S, Donald P, Volk P, Pounds T . The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl. 1998; 534:1-11. DOI: 10.1080/00016489850183629. View

11.

Miller F, Karnad A, Eng T, Hussey D, McGuff H, Otto R . Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck. 2007; 30(1):28-34. DOI: 10.1002/hed.20654. View

12.

Jungehulsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H . 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000; 123(3):294-301. DOI: 10.1067/mhn.2000.104807. View

13.

Sakai O, Curtin H, Romo L, Som P . Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease. Radiol Clin North Am. 2000; 38(5):979-98, x. DOI: 10.1016/s0033-8389(05)70216-5. View

14.

Anzai Y, Carroll W, Quint D, Bradford C, Minoshima S, Wolf G . Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology. 1996; 200(1):135-41. DOI: 10.1148/radiology.200.1.8657901. View

15.

Vogel W, Schinagl D, van Dalen J, Kaanders J, Oyen W . Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area. Q J Nucl Med Mol Imaging. 2007; 52(1):74-83. View

16.

Kole A, Nieweg O, Pruim J, Hoekstra H, Koops H, Roodenburg J . Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998; 82(6):1160-6. DOI: 10.1002/(sici)1097-0142(19980315)82:6<1160::aid-cncr22>3.0.co;2-3. View

17.

Goerres G, Schmid D, Bandhauer F, Huguenin P, von Schulthess G, Schmid S . Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004; 130(1):105-9. DOI: 10.1001/archotol.130.1.105. View

18.

Ryan W, Fee Jr W, Le Q, Pinto H . Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope. 2005; 115(4):645-50. DOI: 10.1097/01.mlg.0000161345.23128.d4. View

19.

van den Brekel M, Stel H, Castelijns J, Nauta J, van der Waal I, Valk J . Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990; 177(2):379-84. DOI: 10.1148/radiology.177.2.2217772. View

20.

Rusthoven K, Koshy M, Paulino A . The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004; 101(11):2641-9. DOI: 10.1002/cncr.20687. View